Oracle announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify eligible ...
Filled marks show published items; half marks show documents announced or scheduled but not yet public. The device column is ...
Ascletis Reports Promising Preclinical Data for Once-Weekly Oral Obesity Treatments, Advances US Phase 1 Trial ...
PharmaEssentia Accelerates Global Expansion with US and Japan Drug Approvals and US$46 Million Manufacturing Investment ...
Shenzhen Chipscreen Biosciences Co., Ltd. announced that NW001, a first-in-class epigenetic immune-modulating antibody ...
The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...
UK Collaboration to Explore Digital-First Screening for Early Detection of High Blood Pressure, Expanding Preventive ...
HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and ...
Median 234 days from first CRO contact to site activation, range 74 to 657; median ethics approval 48 days, median governance ...
Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, announced the acquisition of Energon ...
NTL HEALTHCARE, a women's health AI company, announced the global launch of CerviCARE® AI AT, an on-premises version of its ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results